Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function

American Journal of Cardiovascular Drugs

Volumn 6, Issue 4, 2006, Pages 259-263

  Lombardo, Renzo M R ^a   Reina, Caterina ^b   Abrignani, Maurizio G ^a   Rizzo, Patrizia A ^a   Braschi, Annabella ^c   De Castro, Stefano ^d  

^a Azienda Ospedaliera S Antonio di Abate di Trapani   (Italy)

^b Villa dei Gerani   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; NEBIVOLOL;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

EID: 33747867848     PISSN: 11753277     EISSN: 11753277     Source Type: Journal    
DOI: 10.2165/00129784-200606040-00006     Document Type: Article

References (19)

1. Packer M, Bristow MR, Cohn JN, et al., on behalf of The US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-55
2. CIBIS II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial. Lancet 1999; 353: 9-13
3. Cockroft JR, Chowenczyk PHJ, Brett SE, et al. Nebivolol vasodilates human forearm vasculature: evidence for L-arginin/NO dependent mechanism. J Pharmacol Exp Ther 1995; 274: 1067-71
4. Brehm BR, Wolf SC, Bertsch D, et al. Effects of nebivolol on proliferation and apoptosis on human coronary artery smooth muscle and endothelial cells. Cardiovasc Res 2001; 49: 430-9
5. Brehm BR, Wolf SC, Görner S, et al. Effect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot study. Eur J Heart Fail 2002; 4: 757-63
6. Wolf SC, Buck-Muller N, Gorner S, et al. Influence of the beta-blocker nebivolol on the left ventricular function in patients with chronic heart failure. Med Klin 2003; 98: 1-6
7. Brune S, Schmidt T, Tebbe U, et al. Hemodynamic effects of nebivolol at rest and on exertion in patients with heart failure. Angiology 1990; 4: 696-701
8. Nodari S, Metra M, Dei Cas L. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension: a prospective, randomized, comparison of the long-term effects of atenolol vs nebivolol. Eur J Heart Fail 2003; 5: 621-7
9. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2 (5): 358-67
10. Quinones MA, Otto CM, Stoddard M, et al. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-84
11. The MERIT-HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 2001-7
12. Mangrella M, Rossi F, Fici F, et al. Pharmacology of nebivolol. Pharmacol Res 1998; 38: 419-31
13. Uhlir O, Dvorak I, Gregor P, et al. Nebivolol in the treatment of cardiac failure: a double-blind controlled clinical trial. J Card Fail 1997; 3 (4): 271-6
14. Evdokimova AG, Radzevich AE, Tereshchenko OI, et al. Nebivolol in the treatment of ischemic heart disease patients with chronic heart failure. Kardiologiia 2004; 44 (2): 15-8
15. Gromnatskii NI, Dius'mikeeva NB. Effect of nebivolol on remodelling of the heart and vessels and the state of hemodynamics in patients with hypertension. Kardiologiia 2002; 42: 27-30
16. Rousseau MF, Chapelle F, Van Eyll C, et al. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction. J Card Fail 1996; 2 (1): 15-23
17. Wisenbaugh T, Katz I, Davis J, et al. Long term (3 month) effects of a new betablocker (nebivolol) on cardiac performance in dilated cardiomyopathy. J Am Coll Cardiol 1993; 21: 1094-100
18. Kamp O, Sieswerda GT, Visser CA. Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension. Am J Cardiol 2003; 92: 344-8
19. Bristow MR, Roden RL, Lowes BD, et al. The role of third generation β-blocking agents in chronic heart failure. Clin Cardiol 1998; 21 Suppl. I: 3S-13S